Prevention and treatment of hyperphosphatemia in chronic kidney disease.
Vervloet MG, van Ballegooijen AJ.
Kidney Int. 2018 May;93(5):1060-1072. doi: 10.1016/j.kint.2017.11.036. Epub 2018 Mar 23.
Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm.
Rastogi A, Bhatt N, Rossetti S, Beto J.
J Ren Nutr. 2021 Jan;31(1):21-34. doi: 10.1053/j.jrn.2020.02.003. Epub 2020 May 5.
Phosphate intake, hyperphosphatemia, and kidney function.
Rubio-Aliaga I, Krapf R.
Pflugers Arch. 2022 Aug;474(8):935-947. doi: 10.1007/s00424-022-02691-x. Epub 2022 May 5.
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia.
García Martín A, Varsavsky M, Cortés Berdonces M, Ávila Rubio V, Alhambra Expósito MR, Novo Rodríguez C, Rozas Moreno P, Romero Muñoz M, Jódar Gimeno E, Rodríguez Ortega P, Muñoz Torres M.
Endocrinol Diabetes Nutr (Engl Ed). 2020 Mar;67(3):205-215. doi: 10.1016/j.endinu.2019.06.004. Epub 2019 Sep 26.
Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.
Anand A, Aoyagi H.
Medicina (Kaunas). 2023 May 16;59(5):959. doi: 10.3390/medicina59050959.
Dietary Therapy for Managing Hyperphosphatemia.
Narasaki Y, Rhee CM.
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):9-11. doi: 10.2215/CJN.18171120.
Tumor Lysis Syndrome.
Barbar T, Jaffer Sathick I.
Adv Chronic Kidney Dis. 2021 Sep;28(5):438-446.e1. doi: 10.1053/j.ackd.2021.09.007.
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
Coyne DW, Sprague SM, Vervloet M, Ramos R, Kalantar-Zadeh K.
J Nephrol. 2022 Apr;35(3):875-888. doi: 10.1007/s40620-021-01241-5. Epub 2022 Feb 9.
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.
Cernaro V, Longhitano E, Calabrese V, Casuscelli C, Di Carlo S, Spinella C, Gembillo G, Santoro D.
Expert Opin Pharmacother. 2023 Sep-Dec;24(15):1737-1746. doi: 10.1080/14656566.2023.2243817. Epub 2023 Aug 11.
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Sprague SM, Weiner DE, Tietjen DP, Pergola PE, Fishbane S, Block GA, Silva AL, Fadem SZ, Lynn RI, Fadda G, Pagliaro L, Zhao S, Edelstein S, Spiegel DM, Rosenbaum DP.
Kidney360. 2024 May 1;5(5):732-742. doi: 10.34067/KID.0000000000000387. Epub 2024 Feb 7.
